- I-Mab presented clinical data for Givastomig, combining it with nivolumab and mFOLFOX6, while Trump-era tariffs benefited AI stocks.
- AI stocks are benefiting from Trump tariffs and onshoring, alongside potential merger talks involving Northern Trust and Bank of New York Mellon.
Merger talks between The Bank of New York Mellon and Northern Trust were prompted by the firms to assert independence, while both offer asset servicing and money management services.
3 reports, 0 independent
Updated Jun 24
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Merger talks between The Bank of New York Mellon and Northern Trust were prompted by the firms to assert independence, while both offer asset servicing and money management services.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
The Bank of New York Mellon
American investment banking services holding company
-
Northern Trust
American financial services company
Related events
- Ryan Burns was appointed Head of Asset Managers and Private Markets, Americas at Northern Trust.
- Northern Trust filed disclosures regarding share acquisitions and holdings, concurrent with analysts providing price targets and ratings.
- Man Group plc acquired a new position in Northern Trust Corporation.
- Northern Trust has established offices in the Phoenix Metro Area, Arizona, focused on Wealth Management services.
- New banks are entering the financial services market, specifically targeting small-to-mid market companies.
Coverage
Newest first; wire copies grouped- Unknown outlet
- Unknown outlet
- Unknown outlet